Oral naltrexone maintenance treatment for opioid dependence-Reference-Cited by-同舟云学术

Oral naltrexone maintenance treatment for opioid dependence

Published:2011-02-16 Issue: Volume: Page:
ISSN:
Container-title:Cochrane Database of Systematic Reviews
language:
Short-container-title:

Author:

Minozzi Silvia,Amato Laura,Vecchi Simona,Davoli Marina,Kirchmayer Ursula,Verster Annette

Publisher

John Wiley & Sons, Ltd

Link

https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD001333.pub3/epdf/full

Reference64 articles.

1. Naltrexone pharmacotherapy for opioid dependent federal probationers;Cornish;Journal of Substance Abuse Treatment,1997

2. Patients response to naltrexone: issues of acceptance, treatment effects, and frequency of administration;Curran;NIDA Research Monograph Series,1976

3. Efficacy of naltrexone Hydrochloride for preventing relapse among opiate-dependent patients after detoxification;Guo;Hong Kong Journal of Psychiatry,2001

4. Clinical evaluation of naltrexone treatment of opiate-dependent individuals. Report of the National Research Council Committee on Clinical Evaluation of Narcotic Antagonists;Hollister;Archives of General Psychiatry,1978

5. Naltrexone for heroin dependence treatment in St Petersburg, Russia;Krupitsky;Journal of Substance Abuse Treatment,2004

Cited by 104 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Attitudes toward and training in medications for opioid use disorders: a descriptive analysis among employees in the youth legal system and community mental health centers;Substance Abuse Treatment, Prevention, and Policy;2024-06-21

2. Trends in the Prescribing of Buprenorphine for Opioid Use Disorder, 2019-2023;Mayo Clinic Proceedings: Innovations, Quality & Outcomes;2024-06

3. Cost-effectiveness of full and partial opioid agonists for opioid use disorder in outpatient settings: United States healthcare sector perspective;Journal of Substance Use and Addiction Treatment;2024-05

4. Low-dose naltrexone’s utility for non-cancer centralized pain conditions: a scoping review;Pain Medicine;2023-06-11

5. Critical access medication for opioid use disorder (MOUD) treatment facilities in the continental United States;Drug and Alcohol Dependence Reports;2023-03